Immunotherapy, a rapidly evolving field in medicine, has revolutionized cancer treatment by leveraging the body's immune system to fight disease. This guide aims to provide an overview of the fundamental aspects of immunotherapy, enabling physicians to better understand and apply this treatment modality in clinical practice.
Immunotherapy works on the principle of enhancing the immune system's ability to detect and destroy cancer cells. It involves the use of treatments that stimulate immune responses or counteract mechanisms that cancer cells use to evade the immune system. There are several types of immunotherapies including immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies.
Immune checkpoint inhibitors are drugs that block immune checkpoints - proteins that prevent immune cells from attacking non-harmful cells in the body. Some cancer cells exploit these checkpoints to avoid being targeted by the immune system. By blocking these checkpoints, these inhibitors enable the immune system to recognize and attack cancer cells.
Cancer vaccines, unlike traditional vaccines, are usually given after a cancer diagnosis to stimulate the immune system to attack cancer cells. They can be made from a variety of materials, including cells, proteins, or DNA, and can be patient-specific or off-the-shelf.
Adoptive cell therapies involve the use of T-cells, a type of white blood cell, to fight cancer. In some therapies, T-cells are removed from a patient, genetically modified to recognize specific cancer cells, and then infused back into the patient.
Immunotherapy represents a significant advancement in cancer treatment, offering new hope to patients with various types of malignancies. As research continues to evolve, it's crucial for physicians to stay informed about these developments to provide the best possible care for their patients. Understanding the fundamentals of immunotherapy is the first step in this important journey.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation